MIDTNET SECTOR REPORT

1. MIDTNET SECTOR REPORT LIFE SCIENCE SUMMARY prepared by INNOVATION CENTER DENMARK

2. MIDTNET SECTOR REPORT LIFE SCIENCE FOCUS AREAS IN SHANGHAI • Elderly Care • New Drug Discovery • IVF-ET • TCM Development

3. MIDTNET SECTOR REPORT ELDERLY CARE: Challenges & Obstacles • Lack of Care Products for the Elderly • Inadequate Human and Material Resources • Developing Home Care Services • The Chinese Tradition and Expectations from the Elderly • Pursuit of Higher Life Quality • Preference to Stay in a Care Home • Affordability by the Elderly • Low Pension of Retired People • Families of ‘421’ Structure

4. MIDTNET SECTOR REPORT ELDERLY CARE: Conclusions & Suggestions • A huge demand for proper affordable elder care facilities • A great need for comprehensive solutions in local hospitals • toilets, kitchen wares, beds, movement auxiliaries, fitness equipment and all kinds of software • well-trained elder care nurses

5. MIDTNET SECTOR REPORT ELDERLY CARE: Potential Partners/ Competitors • Personal Care Products • Massagers, thermotherapy machine, lavipeditum instruments, etc. • (Massagers for elderly are very popular products on the Chinese market.) • Electronic Hearing Aids • (International brands dominate this part of the market in China.) • Personal Monitoring Instruments  • The Electronic Sphygmomanometer • (Omron is now the largest manufacturer nationwide.) • The Electronic Blood Glucose Monitor • (Foreign brands such as Johnson and Johnson (U.S) and Roche (Germany) occupy the majority of the market.)

6. MIDTNET SECTOR REPORT ELDERLY CARE: Potential Partners/ Competitors • The Rehabilitation Department of Zhongshan Hospital, Fudan University • The Rehabilitation Department of Huashan Hospital • The Rehabilitation Department of Ruijin Hospital • The Rehabilitation and Sports Medicine Department of Shanghai Medical College, Fudan University

7. MIDTNET SECTOR REPORT NEW DRUG DISCOVERY : Two Major Groups of Enterprises • Pharmaceutical manufacturers • Large CROs

8. MIDTNET SECTOR REPORT Pharmaceutical Manufacturers: Potential Partners/ Competitors • Fosun Pharma • The most active and innovative pharmaceutical enterprise in China, which focuses on Diabetics, Hepatopathy, Cardiovascular, Oncology, and Infection • Shanghai Pharmaceuticals Holding Co., Ltd • The largest medical group, whose department of raw materials is responsible for the manufacturing of bulk drugs for nervus centralis, respiratory system, antibiotic, diabetes, anti-anaphylaxis, anti-tumor, angiocarpy, and mental diseases • Hutchison Medipharma • Focusing on oncology, autoimmune disease and diabetes • Simcere Pharma • A leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug • HengRui Medicine • Primarily in anti-cancer, antineoplastics, angiomyocardiac, analgesic and antibiotics, etc

9. MIDTNET SECTOR REPORT Large CROs: Potential Partners/ Competitors • Wuxi Pharma • A R&D outsourcing company that focuses on pharmaceuticals, biotechnology and medical devices • ChemExplorer / ChemPartner • One of the leading integrated chemistry service organizations in China/ An exclusive outsourcing company of a major U.S. Pharmaceutical company

10. MIDTNET SECTOR REPORT IVF-ET: Challenges & Obstacles • Delaying Marriage and Childbearing Age • The average marriage age is 32.05 for male and 29.38 for female in 2009. • In 2008, women’s age at first childbearing was 27.9 in Shanghai. • Rising Infertility Cases • The infertility rate among these couples has exceeded 10%, and is continuously increasing. • High Cost of IVF • The total cost shall be between 20,000~30,000 CNY. • Unstable Success Rate • Limited Resources of IVF medicine

11. MIDTNET SECTOR REPORT IVF-ET : Conclusions & Suggestions • A huge demand for advanced technologies and facilities

12. MIDTNET SECTOR REPORT IVF-ET: Potential Partners/ Competitors • International Peace Maternity and Child Hygiene Hospital. • The success rate of IVF-ET in 2002 was 43.96%. • Ruijin Hospital, Shanghai Jiaotong University School of Medicine • Renji Hospital, Shanghai Jiaotong University School of Medicine • ShangHai JiAi Genetics & IVF Institute • Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine • Shanghai First Maternity and Child Hygiene Hospital • Shanghai Red House Hospital of Obstetrics and Gynecology

13. MIDTNET SECTOR REPORT TCM DEVELOPMENT: Challenges & Obstacles • Hard to ration out all ingredients • Hard to analyze effective components • Hard to find out essential active substances

14. MIDTNET SECTOR REPORT TCM DEVELOPMENT: Conclusions & Suggestions • Need for help to improve the extraction methods and efficiency and • Need for analysis and identification of effective components as well as doing the experimental analysis afterwards • Further development of the ingredients that cannot be developed into medicine

15. MIDTNET SECTOR REPORT TCM DEVELOPMENT : Potential Partners/ Competitors • Famous TCM Companies in Shanghai • Shanghai Leiyunshang Medicine Co., Ltd. • Afflicted to Shanghai Pharmaceuticals Holdings Co., Ltd., Leiyunshang has a GMP base for mass manufacturing TCM which is able to produce over 20 dosage forms and 500 types. • Tonghanchun Tang • Caitongde Tang • Huqingyu Tang

16. MIDTNET SECTOR REPORT TCM DEVELOPMENT : Potential Partners/ Competitors • Famous TCM Institutes in Shanghai • Shanghai University of T.C.M • Shanghai Institute of Chinese Meteria Medica • School of Pharmacy, Fudan University • Shanghai Shuguang Hospital, Shanghai University of T.C.M • Shanghai Longhua Hospital, Shanghai University of T.C.M